SANOFI-AVENTIS (EPA:SAN)

BRIEF

published on 12/15/2025 at 07:05, 1 month 16 days ago

Sanofi's Tolebrutinib Regulatory Submission Delayed

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
BRIEF

published on 12/15/2025 at 07:05, 1 month 16 days ago

Le dépôt de la demande d'autorisation de mise sur le marché du tolebrutinib de Sanofi est retardé.

FDA Sclérose En Plaques Sanofi Tolebrutinib Retard Réglementaire
PRESS RELEASE

published on 12/15/2025 at 07:05, 1 month 16 days ago

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed

Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
PRESS RELEASE

published on 12/15/2025 at 07:05, 1 month 16 days ago

Communiqué de presse : Sanofi fait le point sur le tolébrutinib dans la sclérose en plaques primaire progressive
Sanofi annonce l'arrêt du développement du tolebrutinib dans la sclérose en plaques primaire progressive après l'étude de phase 3 PERSEUS. Profil de sécurité cohérent, analyse détaillée à venir

Sclérose En Plaques Sanofi Étude Tolebrutinib PERSEUS
PRESS RELEASE

published on 12/15/2025 at 07:00, 1 month 16 days ago

Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolébrutinib dans la sclérose en plaques secondaire progressive non-récurrente
Sanofi retarde la soumission réglementaire du tolébrutinib pour la SEPSPnr, attend des orientations supplémentaires de la FDA au premier trimestre 2026

FDA Sclérose En Plaques Sanofi Tolebrutinib SEPSPnr
PRESS RELEASE

published on 12/15/2025 at 07:00, 1 month 16 days ago

Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi anticipates a delay in tolebrutinib regulatory decision for nrSPMS, with ongoing discussions with the FDA. An expanded access protocol has been submitted for eligible patients

FDA Sanofi Tolebrutinib Regulatory Submission NrSPMS
BRIEF

published on 12/11/2025 at 07:05, 1 month 20 days ago

Percée majeure de Sanofi en Chine avec les approbations de Qfitlia et Cablivi

Sanofi Maladies Rares Qfitlia Cablivi Approbations De La Chine
BRIEF

published on 12/11/2025 at 07:05, 1 month 20 days ago

Sanofi obtient l'approbation en Chine pour Qfitlia et Cablivi

Chine Sanofi Maladies Rares Qfitlia Cablivi
BRIEF

published on 12/11/2025 at 07:05, 1 month 20 days ago

Sanofi obtains approval in China for Qfitlia and Cablivi

China Sanofi Rare Diseases Qfitlia Cablivi
BRIEF

published on 12/11/2025 at 07:05, 1 month 20 days ago

Sanofi's Breakthrough in China with Qfitlia and Cablivi Approvals

Sanofi Rare Diseases Qfitlia Cablivi China Approvals

Published on 01/31/2026 at 03:15, 17 hours 49 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 18 hours 44 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 19 hours 24 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 21 hours 4 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 22 hours 4 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 5 hours 9 minutes ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 8 hours 38 minutes ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 18 hours 18 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 23 hours 4 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 18:40, 1 day 2 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 1 day 3 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 1 day 3 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 3 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 1 day 12 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News